Direkt zum Inhalt
Merck

[Drug treatments, from chlorpromazine to new molecules].

Soins. Psychiatrie (2013-06-14)
Adeline Gaillard, Marie-France Poirier
ZUSAMMENFASSUNG

The history of drug treatments, and particularly the discovery of certain molecules, led toan evolution in psychiatric practices. The discovery of the therapeutic properties of chlorpromazine in 1952 by Jean Delay and Pierre Deniker revolutionised the relational process between patients and caregivers.The perspectives are encouraging, notably in the areas of schizophrenia and mood disorders.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Chlorpromazin -hydrochlorid, ≥98% (TLC)
Supelco
Chlorpromazine hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Chlorpromazin -hydrochlorid, meets USP testing specifications
Supelco
Chlorpromazin -hydrochlorid, VETRANAL®, analytical standard
Chlorpromazin -hydrochlorid, European Pharmacopoeia (EP) Reference Standard